| 1 |
35241462 |
10.1136/bmjopen-2020-041961 |
2022 |
Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis. |
MKI67 |
| 2 |
35248490 |
10.1016/j.clbc.2022.02.001 |
2022 |
Changes in Ki-67 in Residual Tumor and Outcome of Primary Inflammatory Breast Cancer Treated With Trimodality Therapy. |
MKI67 |
| 3 |
35393909 |
10.1080/09513590.2022.2061454 |
2022 |
Effects of clinical and metabolic variables and hormones on the expression of immune protein biomarkers in the endometrium of women with polycystic ovary syndrome and normal-cycling controls. |
MKI67 |
| 4 |
35583604 |
10.1158/1078-0432.CCR-21-3347 |
2022 |
Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL. |
MKI67 |
| 5 |
32873701 |
10.1136/jclinpath-2020-206956 |
2021 |
Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody. |
MKI67 |
| 6 |
33136585 |
10.1097/PAS.0000000000001609 |
2021 |
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy. |
MKI67 |
| 7 |
33404293 |
10.1080/15548627.2020.1871204 |
2021 |
BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes. |
MKI67 |
| 8 |
33723149 |
10.4103/jcrt.JCRT_311_19 |
2021 |
Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma. |
MKI67 |
| 9 |
33737021 |
10.1016/j.taap.2021.115491 |
2021 |
Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression. |
MKI67 |
| 10 |
33788720 |
10.21873/anticanres.14886 |
2021 |
Tumor Cell Microenvironment and Microvessel Density Analysis in MALT Type Lymphoma. |
MKI67 |
| 11 |
33941102 |
10.1186/s12885-021-08142-7 |
2021 |
Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma. |
MKI67 |
| 12 |
33991204 |
10.1007/s00277-021-04473-4 |
2021 |
Elevated expression of HMGB1 is prognostic of poor survival in patients with relapsed/refractory T/NK-CL. |
MKI67 |
| 13 |
34258959 |
10.7754/Clin.Lab.2021.201132 |
2021 |
Prognostic Values of MicroRNA-21 and Ki-67 in Diffuse Large B-Cell Lymphoma Patients: Egyptian Experience. |
MKI67 |
| 14 |
34339560 |
10.1111/pin.13148 |
2021 |
Diagnostic utility and prognostic significance of the Ki-67 labeling index in diffuse large B-cell lymphoma transformed from follicular lymphoma: a study of 76 patients. |
MKI67 |
| 15 |
34535585 |
10.1159/000518452 |
2021 |
Efficacy of the Antigenicity-Retaining Ability of Fixative Solutions for Liquid-Based Cytology: Immunocytochemistry of Long-Term Storage. |
MKI67 |
| 16 |
34898577 |
10.3390/curroncol28060383 |
2021 |
Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study. |
MKI67 |
| 17 |
31698053 |
10.1016/j.micpath.2019.103845 |
2020 |
Epigenetics evaluation of the oncogenic mechanisms of two closely related bovine and human deltaretroviruses: A system biology study. |
MKI67 |
| 18 |
32059385 |
10.3390/medicina56020072 |
2020 |
Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity. |
MKI67 |
| 19 |
32443328 |
10.1097/MD.0000000000020140 |
2020 |
Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography. |
MKI67 |
| 20 |
32556361 |
10.2340/00015555-3578 |
2020 |
Stage-dependent Increase in Expression of miR-155 and Ki-67 and Number of Tumour-associated Inflammatory Cells in Folliculotropic Mycosis Fungoides. |
MKI67 |
| 21 |
32727513 |
10.1186/s12885-020-07200-w |
2020 |
Comprehensive analysis of spread through air spaces in lung adenocarcinoma and squamous cell carcinoma using the 8th edition AJCC/UICC staging system. |
MKI67 |
| 22 |
32767162 |
10.1007/s10637-020-00979-2 |
2020 |
Glioma progression is suppressed by Naringenin and APO2L combination therapy via the activation of apoptosis in vitro and in vivo. |
MKI67 |
| 23 |
32843697 |
10.1038/s41598-020-71058-y |
2020 |
Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy. |
MKI67 |
| 24 |
30224636 |
10.1038/s41401-018-0108-5 |
2019 |
CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression. |
MKI67 |
| 25 |
30328119 |
10.1111/cup.13375 |
2019 |
Utility of CD30, Ki-67, and p53 in assisting with the diagnosis of mycosis fungoides with large cell transformation. |
MKI67 |
| 26 |
30446982 |
10.1007/s10753-018-0930-4 |
2019 |
Breast Implant Texturization Does Not Affect the Crosstalk Between MSC and ALCL Cells. |
MKI67 |
| 27 |
30467824 |
10.14670/HH-18-067 |
2019 |
Next-generation sequencing-based characterization of the invasion by anatomical contiguity in a primary osseous diffuse large B-cell lymphoma. Correlation between the genetic profile of the malignancy and the clinical outcome of the patient. |
MKI67 |
| 28 |
30768440 |
10.1097/PAS.0000000000001233 |
2019 |
SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. |
MKI67 |
| 29 |
30964854 |
10.12659/MSM.914934 |
2019 |
The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway. |
MKI67 |
| 30 |
31219818 |
10.1097/PAS.0000000000001312 |
2019 |
Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases. |
MKI67 |
| 31 |
31259656 |
10.1080/10428194.2019.1633629 |
2019 |
The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma. |
MKI67 |
| 32 |
31492883 |
10.1038/s41598-019-49326-3 |
2019 |
Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy. |
MKI67 |
| 33 |
27490760 |
10.1097/PAI.0000000000000424 |
2018 |
Prognostic Significance of High Ki-67 Index and Histogenetic Subclassification in Primary Central Nervous System Lymphoma. |
MKI67 |
| 34 |
28868942 |
10.1080/10428194.2017.1370547 |
2018 |
MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes. |
MKI67 |
| 35 |
29196411 |
10.1182/blood-2017-07-797019 |
2018 |
Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network. |
MKI67 |
| 36 |
29319177 |
10.1111/cei.13099 |
2018 |
Characterization of ectopic lymphoid structures in different types of acute renal allograft rejection. |
MKI67 |
| 37 |
29579328 |
10.1002/cncr.31328 |
2018 |
Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy. |
MKI67 |
| 38 |
29785709 |
10.1111/bjh.15411 |
2018 |
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL). |
MKI67 |
| 39 |
30272319 |
10.3892/or.2018.6743 |
2018 |
Effects of 60 kDa prolactin and estradiol on metabolism and cell survival in cervical cancer: Co‑expression of their hormonal receptors during cancer progression. |
MKI67 |
| 40 |
30385732 |
10.1172/jci.insight.120974 |
2018 |
Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. |
MKI67 |
| 41 |
28270020 |
10.1080/10428194.2017.1298754 |
2017 |
18F-FDG PET/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. |
MKI67 |
| 42 |
26272457 |
10.1111/his.12808 |
2016 |
Analysis of NSCLC tumour heterogeneity, proliferative and 18F-FDG PET indices reveals Ki67 prognostic role in adenocarcinomas. |
MKI67 |
| 43 |
26926679 |
10.1200/JCO.2015.63.8387 |
2016 |
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network. |
MKI67 |
| 44 |
27959929 |
10.1371/journal.pmed.1002197 |
2016 |
Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study. |
MKI67 |
| 45 |
25381338 |
10.1158/1078-0432.CCR-14-1913 |
2015 |
Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer. |
MKI67 |
| 46 |
25431344 |
10.1111/his.12624 |
2015 |
Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma. |
MKI67 |
| 47 |
25504496 |
10.1007/s12185-014-1719-3 |
2015 |
High Ki-67 expression in involved bone marrow predicts worse clinical outcome in diffuse large B cell lymphoma patients treated with R-CHOP therapy. |
MKI67 |
| 48 |
25573205 |
10.3109/10428194.2015.1004169 |
2015 |
Prognostic effect of Ki-67 expression in rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-treated diffuse large B-cell lymphoma is limited to non-germinal center B-cell-like subtype in late-elderly patients. |
MKI67 |
| 49 |
25648135 |
10.1007/s10549-015-3288-4 |
2015 |
Bcl2 and Ki67 refine prognostication in luminal breast cancers. |
MKI67 |
| 50 |
25712457 |
10.1093/annonc/mdv074 |
2015 |
Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL). |
MKI67 |
| 51 |
26107196 |
10.7314/apjcp.2015.16.11.4515 |
2015 |
Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma. |
MKI67 |
| 52 |
26546525 |
|
2015 |
Suppression of BCL2 by Antisense Oligonucleotides and Compensation by Non-Targeted Genes May Enhance Tumor Proliferation. |
MKI67 |
| 53 |
24013721 |
10.1038/cdd.2013.123 |
2014 |
The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. |
MKI67 |
| 54 |
24597851 |
10.1186/1471-2407-14-153 |
2014 |
Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. |
MKI67 |
| 55 |
24684350 |
10.1111/bjh.12854 |
2014 |
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic Lymphoma Group study. |
MKI67 |
| 56 |
25204411 |
10.1007/s12032-014-0218-y |
2014 |
Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type. |
MKI67 |
| 57 |
25374203 |
10.7314/apjcp.2014.15.20.8759 |
2014 |
Distribution of Ki67 proliferative indices among WHO subtypes of non-Hodgkin's lymphoma: association with other clinical parameters. |
MKI67 |
| 58 |
23240716 |
10.1111/his.12009 |
2013 |
Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression. |
MKI67 |
| 59 |
24471040 |
10.5125/jkaoms.2013.39.4.182 |
2013 |
Expansile keratocystic odontogenic tumor in the maxilla: immunohistochemical studies and review of literature. |
MKI67 |
| 60 |
22531522 |
10.4103/0973-1482.95182 |
2012 |
Correlation of fluorodeoxyglucose uptake and tumor-proliferating antigen Ki-67 in lymphomas. |
MKI67 |
| 61 |
21738398 |
|
2011 |
Expression of cell proliferation and apoptosis biomarkers in pterygia and normal conjunctiva. |
MKI67 |
| 62 |
20038236 |
10.3109/10428190903440953 |
2010 |
SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. |
MKI67 |
| 63 |
20181625 |
|
2010 |
Molecular profiling using tissue microarrays as a tool to identify predictive biomarkers in laryngeal cancer treated with radiotherapy. |
MKI67 |
| 64 |
20369488 |
|
2010 |
[Expression and significance of P53 and P21 in nasal NK/T-cell lymphoma]. |
MKI67 |
| 65 |
20530581 |
10.1158/1541-7786.MCR-10-0131 |
2010 |
PRDM1 is required for mantle cell lymphoma response to bortezomib. |
MKI67 |
| 66 |
20882047 |
10.1038/leu.2010.221 |
2010 |
COX-2 is a novel target in therapy of mycosis fungoides. |
MKI67 |
| 67 |
18778369 |
10.1111/j.1600-0609.2008.01152.x |
2009 |
Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma. |
MKI67 |
| 68 |
19452712 |
|
2009 |
[Expressions of p53 and p21 in nasal NK/T-cell lymphoma and their relationship with the proliferation and apoptosis of cells]. |
MKI67 |
| 69 |
20001925 |
10.2174/092986609789353646 |
2009 |
Proteomic analysis of mitochondria in Raji cells following exposure to radiation: implications for radiotherapy response. |
MKI67 |
| 70 |
18077791 |
10.1182/blood-2007-10-117010 |
2008 |
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. |
MKI67 |
| 71 |
18612102 |
10.1182/blood-2008-03-145128 |
2008 |
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). |
MKI67 |
| 72 |
18766962 |
10.1080/10428190802140055 |
2008 |
Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma. |
MKI67 |
| 73 |
17296585 |
10.3324/haematol.10682 |
2007 |
MUM1 expression dichotomises follicular lymphoma into predominantly, MUM1-negative low-grade and MUM1-positive high-grade subtypes. |
MKI67 |
| 74 |
17693651 |
10.1093/annonc/mdm183 |
2007 |
Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. |
MKI67 |
| 75 |
16623776 |
10.1111/j.1365-2559.2006.02378.x |
2006 |
Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders. |
MKI67 |
| 76 |
17225522 |
|
2006 |
[Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma]. |
MKI67 |
| 77 |
15931389 |
10.1172/JCI23412 |
2005 |
Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. |
MKI67 |
| 78 |
16295759 |
|
2005 |
[Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. |
MKI67 |
Datasets
Models
